Dietary Effects on Lipoproteins and Thrombogenic Activity
Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · Oct 27, 1999
Trial Information
Current as of March 19, 2025
Completed
Keywords
ClinConnect Summary
BACKGROUND:
A solid foundation of epidemiologic, clinical and laboratory evidence underlies the current dietary recommendations for population-based prevention of coronary heart disease. Average blood cholesterol levels will decline with the consumption of less saturated fat and cholesterol than has been traditional in the United States. It is not clear, however, whether reductions in total fat intake are necessary as well. More research also is needed to define how best to provide a national food supply whose composition will enhance efforts to reduce coronary heart disease risk. Fatty ac...
Gender
ALL
Eligibility criteria
- • Men and women with low HDL and/or high triglyceride levels and/or high insulin levels.
Trial Officials
Patricia Elmer
University of Minnesota
Penny Kris-Etherton
Penn State University
Paul Roheim
Louisiana State University Medical Center
Henry Ginsberg
Columbia University
About University Of North Carolina, Chapel Hill
The University of North Carolina at Chapel Hill (UNC) is a leading research institution renowned for its commitment to advancing health and science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, UNC conducts cutting-edge research across various fields, including medicine, public health, and biomedical sciences. The university is dedicated to improving patient care and health outcomes by translating its research findings into practical applications. UNC’s clinical trials are designed to evaluate new therapies, interventions, and technologies, ensuring that they meet the highest ethical and scientific standards while fostering a culture of inclusivity and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
Similar Trials